Page last updated: 2024-10-25

desipramine and Cholestasis

desipramine has been researched along with Cholestasis in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Cholestasis: Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).

Research Excerpts

ExcerptRelevanceReference
" Knowledge of the drug dose-response curve and its levels in blood may enable the physician to convert a patient from a "nonresponder" into a "responder."1.26High dose desipramine, plasma drug levels and clinical response. ( Amsterdam, J; Brunswick, DJ; Mendels, J, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amsterdam, J1
Brunswick, DJ1
Mendels, J1

Other Studies

1 other study available for desipramine and Cholestasis

ArticleYear
High dose desipramine, plasma drug levels and clinical response.
    The Journal of clinical psychiatry, 1979, Volume: 40, Issue:3

    Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Cholestasis; Depression; De

1979